Rapilif D 8/0.5 Combipack

Rapilif D 8/0.5 Combipack is prescribed to treat benign prostatic hyperplasia (BPH) in adult males to alleviate urinary symptoms and reduce the risk of acute urinary retention or the need for surgery.

Silodosin is an alpha blocker, while Dutasteride is a 5-alpha reductase inhibitor. Both work differently but target symptoms associated with an enlarged prostate.

Take the prescribed dosage orally, typically once daily, as directed by a healthcare professional. Consistency in taking these medications regarding meals may be advised but follow the specific instructions given by your doctor.

Adhering to the prescribed dosage and guidance from a healthcare provider is essential for effectively managing benign prostatic hyperplasia with the combination of Silodosin and Dutasteride. If you experience any adverse effects or have concerns, consult your healthcare professional promptly.